BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
Bio-Techne (NASDAQ: TECH) will showcase its neuroscience research solutions at Neuroscience 2024, the Society for Neuroscience (SfN) annual meeting, from October 5-9, 2024, in Chicago. The company will present its portfolio of life science reagents, immunoassays, automated proteomic instruments, and multiomics solutions at booth #1165.
Key highlights include:
- A nanosymposium on brain senescence using the RNAscope™ Multiomic LS assay
- A poster on antibody validation for the COMET™ spatial biology platform
- A Product Theater presentation with FUJIFILM Cellular Dynamics on Alzheimer's disease intracellular signaling using Simple Western™ technology
- Multiple poster presentations on topics such as pTau217 quantification, synaptic research, interneuron heterogeneity, and glioblastoma biomarker evaluation
Bio-Techne's CEO, Kim Kelderman, emphasized the company's commitment to advancing neuroscience research and enabling next-generation therapies.
Bio-Techne (NASDAQ: TECH) presenterà le sue soluzioni di ricerca neuroscientifica a Neuroscience 2024, il congresso annuale della Society for Neuroscience (SfN), dal 5 al 9 ottobre 2024, a Chicago. L'azienda esporrà il suo portfolio di reagenti per le scienze della vita, immunoassay, strumenti proteomici automatizzati e soluzioni multiomiche allo stand #1165.
Tra i principali punti salienti ci sono:
- Un nanosimposio sulla senescenza cerebrale utilizzando l'RNAscope™ Multiomic LS assay
- Un poster sulla validazione degli anticorpi per la piattaforma di biologia spaziale COMET™
- Una presentazione al Product Theater con FUJIFILM Cellular Dynamics sul segnale intracellulare della malattia di Alzheimer utilizzando la tecnologia Simple Western™
- Molteplici presentazioni di poster su argomenti come la quantificazione di pTau217, la ricerca sinaptica, l'eterogeneità degli interneuroni e la valutazione dei biomarcatori del glioblastoma
Il CEO di Bio-Techne, Kim Kelderman, ha sottolineato l'impegno dell'azienda per il progresso della ricerca neuroscientifica e per l'abilitazione delle terapie di nuova generazione.
Bio-Techne (NASDAQ: TECH) mostrará sus soluciones de investigación en neurociencia en Neuroscience 2024, la reunión anual de la Society for Neuroscience (SfN), del 5 al 9 de octubre de 2024, en Chicago. La empresa presentará su portafolio de reactivos de ciencias de la vida, inmunoensayos, instrumentos proteómicos automatizados y soluciones multiómicas en el stand #1165.
Los puntos destacados incluyen:
- Un nanosimposio sobre senescencia cerebral utilizando el RNAscope™ Multiomic LS assay
- Un póster sobre la validación de anticuerpos para la plataforma de biología espacial COMET™
- Una presentación en el Product Theater con FUJIFILM Cellular Dynamics sobre la señalización intracelular de la enfermedad de Alzheimer utilizando la tecnología Simple Western™
- Múltiples presentaciones de pósteres sobre temas como la cuantificación de pTau217, la investigación sináptica, la heterogeneidad de interneurones y la evaluación de biomarcadores de glioblastoma
El CEO de Bio-Techne, Kim Kelderman, enfatizó el compromiso de la empresa con el avance de la investigación en neurociencia y la habilitación de nuevas terapias de generación.
Bio-Techne (NASDAQ: TECH)는 2024년 10월 5일부터 9일까지 시카고에서 열리는 신경과학 학회(SfN) Neuroscience 2024에서 신경과학 연구 솔루션을 소개합니다. 이 회사는 부스 번호 #1165에서 생명 과학 시약, 면역 분석, 자동화된 단백질체 분석기 및 다중 오믹스 솔루션 포트폴리오를 선보일 예정입니다.
주요 하이라이트는 다음과 같습니다:
- RNAscope™ Multiomic LS assay를 사용한 뇌 노화에 관한 나노 심포지엄
- COMET™ 공간 생물학 플랫폼을 위한 항체 검증에 대한 포스터
- 알츠하이머병 세포 내 신호 전달에 관한 FUJIFILM Cellular Dynamics와의 Product Theater 발표, Simple Western™ 기술 사용
- pTau217 정량화, 시냅스 연구, 내부 신경 세포 이질성 및 교모세포종 바이오마커 평가와 같은 주제에 대한 여러 포스터 발표
Bio-Techne의 CEO인 Kim Kelderman은 신경과학 연구를 발전시키고 차세대 치료법을 가능하게 하려는 회사의 노력을 강조했습니다.
Bio-Techne (NASDAQ: TECH) présentera ses solutions de recherche en neurosciences lors de Neuroscience 2024, la réunion annuelle de la Society for Neuroscience (SfN), du 5 au 9 octobre 2024, à Chicago. L'entreprise présentera son portefeuille de réactifs en sciences de la vie, immunoessais, instruments protéomiques automatisés et solutions multiomiques au stand #1165.
Les points forts incluent :
- Un nanosymposium sur la sénescence cérébrale utilisant le RNAscope™ Multiomic LS assay
- Un poster sur la validation des anticorps pour la plateforme de biologie spatiale COMET™
- Une présentation au Product Theater avec FUJIFILM Cellular Dynamics sur le signal intracellulaire de la maladie d'Alzheimer utilisant la technologie Simple Western™
- De nombreuses présentations de posters sur des sujets tels que la quantification de pTau217, la recherche synaptique, l'hétérogénéité des interneurones et l'évaluation des biomarqueurs de glioblastome
Le PDG de Bio-Techne, Kim Kelderman, a souligné l'engagement de l'entreprise à faire avancer la recherche en neurosciences et à permettre de nouvelles thérapies de génération.
Bio-Techne (NASDAQ: TECH) wird seine Neurowissenschafts-Forschungslösungen auf Neuroscience 2024, dem jährlichen Treffen der Society for Neuroscience (SfN), vom 5. bis 9. Oktober 2024 in Chicago präsentieren. Das Unternehmen wird sein Portfolio an Lebenswissenschaft-Reagenzien, Immunoassays, automatisierten proteomischen Instrumenten und Multiomics-Lösungen am Stand #1165 vorstellen.
Wichtige Highlights sind:
- Ein Nanosymposium zur ZNS-Seneszenz unter Verwendung des RNAscope™ Multiomic LS Assay
- Ein Poster zur Antikörpervalidierung für die COMET™ Plattform der räumlichen Biologie
- Eine Präsentation im Product Theater mit FUJIFILM Cellular Dynamics zur intrazellulären Signalübertragung bei Alzheimer mit Simple Western™-Technologie
- Mehrere Posterpräsentationen zu Themen wie der Quantifizierung von pTau217, synaptischer Forschung, Interneuronheterogenität und der Bewertung von Glioblastom-Biomarkern
Der CEO von Bio-Techne, Kim Kelderman, betonte das Engagement des Unternehmens zur Förderung der neurowissenschaftlichen Forschung und zur Ermöglichung neuester Therapien.
- None.
- None.
At booth #1165, Bio-Techne will feature its market-leading portfolio of high-quality life science reagents, immunoassays, automated proteomic analytical instruments, and multiomics solutions. These technologies are accelerating research by streamlining biomarker discovery and quantification, optimizing neural cell cultures and organoid models, and transforming drug discovery and screening processes.
In a nanosymposium, Bio-Techne will discuss a study investigating senescence in the aging brain, highlighting the novel RNAscope™ Multiomic LS assay for high-throughput spatial analysis. Additionally, the team will present a poster detailing Bio-Techne's commitment to antibody validation for use on COMETTM, the fully automated, high-throughput, hyperplex spatial biology platform from LunaphoreTM, a Bio-Techne brand.
Bio-Techne will also host a Product Theater presentation in collaboration with FUJIFILM Cellular Dynamics, Inc. The presentation will focus on intracellular signaling in Alzheimer's disease, including the use of Simple Western™ automated western technology for protein size characterization and quantification directly in complex samples like cell and tissue lysates. This technology will be further highlighted in a poster presentation from Cell Signaling Technology, demonstrating its use in characterizing iPSC-derived microglial activation.
"We are proud to support the advancement of neuroscience research with our portfolio of innovative proteomic research tools, research reagents, and spatial biology solutions," said Kim Kelderman, Bio-Techne's President and Chief Executive Officer. "Scientists rely on our suite of cutting-edge solutions to further the understanding of neuroscience and other biological processes, enabling the development of next-generation therapies and treatments. We are looking forward to showcasing our solutions at this important conference."
To learn more about Bio-Techne's activities at Neuroscience 2024, visit https://www.bio-techne.com/about/events/SfN.
Bio-Techne Speaker Presentations:
Simple Western™ Capillary Immunoassays: A Game Changer in Elucidating Intracellular Signaling in Alzheimer's Disease
Monday, October 7 at 2:30pm
Presenters: Scott Schachtele, PhD, Product Manager, Neuroscience, FUJIFILM Cellular Dynamics
Charles Haitjema, Senior Research Area Manager, Analytical Solutions Division, Bio-Techne
Location: Exhibit Hall, Aisle 900, Product Theater 1
Investigating Hallmarks of Senescence in the Aging Brain Using a Novel RNA-Protein Multiomic Co-Detection Assay
Wednesday, October 9, 3:00pm - 3:15pm
Presenter: Debia Wakhloo, PhD, Application Scientist, Marketing
Location: MCP Room S106
Bio-Techne Poster Presentations: An Automated Assay for Precise and Sensitive Quantification of pTau217 in Plasma and Cerebrospinal Fluid
Sunday, October 6, 3:00pm – 4:00pm
Presenter: Yoav Noam, PhD, Senior Manager, Research & Development
Poster Session: LBA003 – Theme C, Late Breaking Posters
Abstract: 13849
Bridging the Gap in Synaptic Research: Visualizing Neurexin and Neuroligin Interactions Using Multiomic RNAscope Technology
Sunday, October 6, 1:00pm – 2:00pm
Presenter: Debia Wakhloo, PhD, Application Scientist, Marketing
Poster Session: PSTR143 – Biochemical and Molecular Technologies I
Abstract: 5821
Spatial Multiomic Assay for Studying Interneuron Heterogeneity in the Brain
Tuesday, October 8, 3:00pm – 4:00pm
Presenter: Anushka Dikshit, PhD, Senior Manager, Applications
Poster Session: LBA009 – Theme I, Late Breaking Posters
Abstract: 13972
Evaluation of IDH1, EGFR, IGF1R and Ki67 Biomarkers in Glioblastoma using Lunaphore COMET™ Platform
Wednesday, October 9, 2:00pm - 3:00pm
Presenter: Alexander Kalyuzhny, PhD, Sr. Manager, Antibody Validation
Poster Session: PSTR444 - Glioblastoma and Other Nervous System Cancers: Mechanisms and Techniques
Abstract: 10867
Poster Presentation, In Collaboration:
Characterization of iPSC-Derived Human Microglial Activation Using Automated, Multiplex Capillary Western Blot Analysis
Sunday, October 6, 10:00am - 11:00am
Presenter: Richard Cho, PhD, Associate Director, Neuroscience, Cell Signaling Technology
Poster Session: PSTR058 - In Vitro Modeling of Neuroinflammation and Neurodegeneration
Abstract: 8455
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-neuroscience-2024the-society-for-neuroscience-sfn-annual-meeting-302244769.html
SOURCE Bio-Techne Corporation
FAQ
What will Bio-Techne (TECH) showcase at Neuroscience 2024?
What new technology will Bio-Techne (TECH) present at SfN 2024?
What is the focus of Bio-Techne's (TECH) Product Theater presentation at Neuroscience 2024?
Which Bio-Techne (TECH) technologies will be highlighted in poster presentations at SfN 2024?
